Evaluation of hereditary/familial breast cancer patients with multigene targeted next generation sequencing panel and MLPA analysis in Turkey
- 16 February 2022
- journal article
- research article
- Published by Elsevier in Cancer Genetics
- Vol. 262-263, 118-133
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A Comprehensive Focus on Global Spectrum ofBRCA1andBRCA2Mutations in Breast CancerBioMed Research International, 2013
- Clinical significance of large rearrangements in BRCA1 and BRCA2Cancer, 2012
- Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patientsCancer Genetics and Cytogenetics, 2010
- Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer familiesBreast Cancer Research and Treatment, 2010
- The Relative Contribution of Point Mutations and Genomic Rearrangements in BRCA1 and BRCA2 in High-Risk Breast Cancer FamiliesCancer Research, 2008
- Breast cancer risk associated with BRCA1 and BRCA2 in diverse populationsNature Reviews Cancer, 2007
- Novel GermlineBRCA1andBRCA2Mutations in Turkish Women with Breast and/or Ovarian Cancer and Their RelativesCancer Investigation, 2006
- Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysisCancer Genetics and Cytogenetics, 2005
- Germline mutations in theBRCA1andBRCA2genes in Turkish breast/ovarian cancer patientsHuman Mutation, 2003
- Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancerEuropean Journal of Cancer, 1999